Refractory cytopenia of childhood is a subgroup of myelodysplastic syndrome (MDS), having been added to the World Health Organization classification in 2008. Before then, RCC cases were classified as childhood aplastic anemia.[1][2] RCC is the most common form of MDS in children and adolescents, accounting for approximately half of all MDS cases.[3]
| Refractory cytopenia of childhood | |
|---|---|
| Other names | RCC |
Presentation edit
Symptoms result from underproduction of red blood cells (weakness, pallor, failure to thrive, pica), white blood cells (recurrent or overwhelming infection), and/or platelets (bleeding).[citation needed]
Histopathologic features edit
The bone marrow of patients with RCC contains islands of erythroid precursors and spare granulocytes. In some scenarios, multiple bone marrow biopsy examinations may be recommended before a diagnosis can be established.[citation needed]
Diagnosis edit
This section is empty. You can help by adding to it. (November 2021) |
Management edit
Bone marrow transplant is the only known curative treatment.[citation needed]
References edit
- ^ Niemeyer, C. M.; Baumann, I (2011). "Classification of childhood aplastic anemia and myelodysplastic syndrome". Hematology. 2011: 84–9. doi:10.1182/asheducation-2011.1.84. PMID 22160017.
- ^ "Medscape Pediatric Myelodysplasia". Retrieved 16 June 2015.
- ^ Niemeyer, C. M.; Baumann, I (2008). "Myelodysplastic syndrome in children and adolescents". Seminars in Hematology. 45 (1): 60–70. doi:10.1053/j.seminhematol.2007.10.006. PMID 18179970.